Ulrich Muehlner

Ulrich Muehlner

Head of Global Strategy at Novartis


Ulrich Muehlner joined Novartis in August 2009 and is

currently Head of Global Corporate Strategy a.i. leading the annual Novartis

Group strategic planning cycle as well as key strategic initiatives ranging

from areas such as emerging markets to new business development.

Prior to joining Novartis Ulrich worked with The Boston

Consulting Group (BCG) as a Principal focusing on serving clients from the

biopharmaceuticals, diagnostics, venture capital/private equity and chemical

industry. His project experience covers areas such as biopharma R&D,

innovation, business model development, business transformation and value

management, carve-outs and due diligences. Based in Vienna, Ulrich led projects

across Europe, USA and Asia.

Before joining BCG, Ulrich studied Biochemistry in Hannover

and Munich and earned a PhD degree in Biochemistry and Molecular Biology based

on his research on molecular mechanisms of blood vessel formation and signal

transduction in oncogenesis at the Research Institute of Molecular Pathology

(I.M.P.) in Vienna.